Literature DB >> 6184611

The functions of endogenous C1q, a subcomponent of the first component of complement, as a receptor on the membrane of macrophages.

M Loos.   

Abstract

C1q, the Fc-recognizing subcomponent of the first component of complement is synthesized by peritoneal macrophages. During the secretion phase C1q serves as an Fc-binding protein in the membrane of macrophages. The Fc-mediated rosette formation was inhibited in a dose-dependent manner when macrophages were pretreated with anti-C1q F(ab')2, whereas C3b rosette formation was not affected. Furthermore, preincubation of peritoneal macrophages with anti-C1q F(ab')2 abolished, dose- and time-dependently, the polyanion-mediated stimulation of secretion of lysosomal enzymes. Polyanion-induced enzyme release was prevented after incubation of polyanions with highly purified C1q. The inhibition of Fc receptor activity by polyanions (i.e. dextran sulfate, liquoid, polyvinyl sulfate) is completely reversed upon treatment of these macrophages with protamine. These findings are compatible with the hypothesis that C1q produced by macrophages serves in the macrophage membrane as an endogenous receptor for Fc and polyanionic molecules. Thus, C1q mediates cell-bound biological receptor functions before it is released from these cells and is incorporated into the macromolecular C1 complex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184611     DOI: 10.1016/0161-5890(82)90288-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

Review 1.  The immunosuppressive effects of bilirubin.

Authors:  V Vĕtvicka; P Síma; I Miler; M Bilej
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 2.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Hepatic uptake of circulating IgG immune complexes.

Authors:  T Skogh; R Blomhoff; W Eskild; T Berg
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

Review 4.  Fc receptor--more answers, more questions.

Authors:  L Fornůsek; V Vĕtvicka
Journal:  Folia Microbiol (Praha)       Date:  1984       Impact factor: 2.099

5.  Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.

Authors:  J C Bensa; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

6.  SLE like syndrome and functional deficiency of C1q in members of a large family.

Authors:  A J Hannema; J C Kluin-Nelemans; C E Hack; A J Eerenberg-Belmer; C Mallée; H P van Helden
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

Review 7.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

8.  Biosynthesis of normal and low-molecular-mass complement component C1q by cultured human monocytes and macrophages.

Authors:  R Hoekzema; M C Brouwer; E R de Graeff-Meeder; H P van Helden; C E Hack
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

9.  Modulation of mRNA expression and secretion of C1q in mouse macrophages by anti-inflammatory drugs and cAMP: evidence for the partial involvement of a pathway that includes cyclooxygenase, prostaglandin E2 and adenylate cyclase.

Authors:  P K Trinder; D Faust; F Petry; M Loos
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.